-

ZOLL Reports Email Phishing Attack

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (“ZOLL”) is notifying individuals who were in contact with ZOLL Respicardia either directly or indirectly through a provider, or whose provider contacted ZOLL Respicardia on their behalf, that their health information may have been accessed by an unauthorized party after a ZOLL employee was the victim of a sophisticated email phishing attack. This incident was limited to emails and had no impact on ZOLL’s medical devices, software, or services. The information affected by the incident may have included some individuals’ names and health information. ZOLL has no indication that the information has been misused. ZOLL is evaluating its cybersecurity education and training measures for employees. Individuals with questions can contact a dedicated call center at 800-459-4255 Monday through Friday from 8 a.m. to 8 p.m. CST, closed Saturday and Sunday (and excluding major U.S. holidays).

Contacts

Matt Hogan
ZOLL
+1 (978) 805-6561
media@zoll.com

ZOLL Medical Corporation


Release Versions

Contacts

Matt Hogan
ZOLL
+1 (978) 805-6561
media@zoll.com

More News From ZOLL Medical Corporation

ZOLL Medical Appoints Eric Knudsen as New CEO

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it has appointed Eric Knudsen as its new Chief Executive Officer, effective April 1. Knudsen will succeed Jon Rennert, who served as ZOLL’s CEO for the past 10 years and will assume a new role as Executive Chairman of ZOLL’s Board of Directors. “As a global leader in medical technology, ZOLL is continually looking for ways to expand our busines...

This Heart Month, ZOLL LifeVest® Goes Red to Spotlight Women’s Cardiac Health

CHELMSFORD, Mass.--(BUSINESS WIRE)--The ZOLL LifeVest® team is “going red” for Heart Month in February 2026 in support of the American Heart Association and their Go Red for Women® initiative to spotlight women's cardiac health. ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that ZOLL’s continuing support of the American Heart Association will include a combination of awareness, advocacy, and fundraising activities and events. “During H...

ZOLL LifeVest® WCD Saved 143 Lives Over the Holiday Season

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that the LifeVest® wearable cardioverter defibrillator (WCD) saved 143 patients between Thanksgiving Day (U.S.) and New Year’s Day, an average of four patients per day. LifeVest is a wearable cardioverter defibrillator (WCD) that is prescribed to heart patients who are at temporary risk of sudden cardiac death due to certain rapid life-threatening heart r...
Back to Newsroom